facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
March 3, 2025 - Deals

Stripes, GIC, Avenir Growth, And Thrive Capital Acquire Ramp From Eric Glyman

Property Image
Ramp, a NYC-based financial operations platform, announced a $150M secondary sale from employees and early investors to new and existing backers, including Stripes, GIC, Avenir Growth, and Thrive Capital, valuing the company at $13B. Founded in 2019 and led by CEO Eric Glyman, Ramp integrates payments, corporate cards, vendor management, and travel booking, helping 30,000+ businesses save $2B and 20M hours. Recent milestones include launching Ramp Procurement, Travel, and Treasury, expanding its App Center to 200+ integrations, and automating 100M+ business workflows. INVESTORS: Stripes, GIC, Avenir Growth, Thrive Capital, Khosla Ventures, General Catalyst, Lux Capital, 137 Ventures & Definition Capital AMOUNT: $150,000,000 VALUATION: $13,000,000,000 HQ: #NewYork #NY #NewYorkCity #NYC #VentureCapital #Ramp #Stripes #GIC #AvenirGrowth #ThriveCapital #KhoslaVentures #GeneralCatalyst #LuxCapital #137Ventures #DefinitionCapital #EricGlyman #TradedVC

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC